Possible Mechanism of Vasogenic Brain Oedema Induced by Arachidonic Acid

  • T. Ohnishi
  • H. Iwasaki
  • T. Hayakawa
  • W. R. Shapiro
Conference paper
Part of the Acta Neurochirurgica book series (NEUROCHIRURGICA, volume 51)


Free archidonic acid was infused into normal rat brains and the effect of arachidonic acid on capillary permeability was investigated by measuring the regional uptake of 14C-aminoisobutyric acid with a quantitative autoradiographic method. Arachidonic acid increased capillary permeability in a dose-dependent manner up to 2 mM. A high dose of arachidonic acid ( > 5 mM) produced a profound tissue destruction around the needle track and less increased capillary permeability than 2 mM arachidonic acid. Time-course study disclosed that arachidonic acid markedly increased capillary permeability within 2 hours after infusion, and continued to increase with time to 24 hours. The effect of 48 hours infusion was about a half of that at 24 hours, indicating that the effect of arachidonic acid was partially reversible. Pretreatment with dexamethasone significantly inhibited the arachidonic acid-induced increase in capillary permeability and the administration of actinomycin D 1 hour before the pretreatment with dexamethasone suppressed the inhibitory effect of dexamethasone. These results suggest that arachidonic acid, which is deposited in the extracellular space, increases brain capillary permeability by two different ways. One is the direct detergent effect of arachidonic acid, and the other is the effect of arachidonic acid that is released from the membrane by the activation of phospholipase A2.


Arachidonic Acid Capillary Permeability Needle Track Krebs Ringer Buffer Vasogenic Brain Oedema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baethmann A, Maier-Hauff K, Schürer L et al (1989) Release of glutamate and of free fatty acids in vasogenic brain oedema. J Neurosurg 70: 578–591PubMedCrossRefGoogle Scholar
  2. 2.
    Black KL, Hoff JT (1985) Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats. Ann Neurol 18: 349–351PubMedCrossRefGoogle Scholar
  3. 3.
    Chan PH, Fishmann RA, Caronna J et al (1983) Induction of brain oedema following intracerebral injection of arachidonic acid. Ann Neurol 13: 625–632PubMedCrossRefGoogle Scholar
  4. 4.
    Hirata F (1981) The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 256: 7730–7733PubMedGoogle Scholar
  5. 5.
    Ohnishi T, Sher PB, Posner JB et al (1990) Capillary permeability factor secreted by malignant brain tumour. Role in peritumoral brain oedema and possible mechanism for anti-oedema effect of glucocorticoids. J Neurosurg 72: 245–251PubMedCrossRefGoogle Scholar
  6. 6.
    Unterberg A, Wahl M, Hammersen F et al (1987) Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid. Acta Neuropathol 73: 209–219PubMedCrossRefGoogle Scholar
  7. 7.
    Wei EP, Ellison MD, Kontos HA et al (1986) 02 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins. Am J Physiol 251: 693–699Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • T. Ohnishi
    • 3
  • H. Iwasaki
    • 1
  • T. Hayakawa
    • 1
  • W. R. Shapiro
    • 2
  1. 1.Department of NeurosurgeryOsaka University Medical SchoolOsakaJapan
  2. 2.Department of NeurologyMemorial Sloan-Kettering Cancer CenterUSA
  3. 3.Department of NeurosurgeryOsaka University Medical SchoolFukushima, Osaka 553Japan

Personalised recommendations